Related Experiment Video
Updated: Jun 30, 2026
12:03
Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
Published on: July 25, 2011
19.5K
Cutaneous SCC with orbital invasion: case series.
M Nägeli1, J Mangana1, K Chaloupka2
1Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Summary
Cutaneous squamous cell carcinoma (cSCC) invading the orbit is challenging to treat. Immune-checkpoint inhibitors showed variable responses in four orbital invasion cases, highlighting the need for interdisciplinary care.
Area of Science:
- Ophthalmology
- Dermatology
- Oncology
Background:
- Cutaneous squamous cell carcinoma (cSCC) is a common orbital tumor.
- Basal cell carcinoma (BCC) is a common eyelid tumor.
- Diagnostic delays for orbital tumors can worsen outcomes.
Observation:
- This study reviewed four cases of cSCC with orbital invasion.
- Patients were treated with immune-checkpoint inhibitors.
- Treatment responses were variable.
Findings:
- cSCC is the most frequent secondary orbital tumor.
- Orbital invasion by cSCC presents therapeutic challenges.
- Immune-checkpoint inhibitors offer a potential treatment avenue with unpredictable efficacy.
Implications:
- Interdisciplinary tumor board discussion is crucial for managing orbital cSCC.
- Further research is needed to optimize immune-checkpoint inhibitor therapy for orbital invasion.
- Early diagnosis and treatment are vital to minimize complications.
